ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1437

Journal of Clinical & Experimental Pathology received 1437 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Level of human Kidney Injury Molecule-1 (KIM-1) as an early marker for diabetic nephropathy in Egyptian type-2 diabetic patients

15th Global Experts Meeting on Pathology and Laboratory Medicine

Hoda Ali Mohamed El-Attar, Khalil G I and Gaber E W

Alexandria University, Egypt

Posters & Accepted Abstracts: J Clin Exp Pathol

DOI: 10.4172/2161-0681-C2-049

Abstract
Background: Human Kidney Injury Molecule-1 (KIM-1) is produced in the affected segments of the proximal renal tubule whenever there is a pathophysiological state resulting in dedifferentiation of the epithelium. The kidney injury molecule-1 is a type-1 transmembrane glycoprotein (339 aa). KIM-1 ectodomain is cleaved and shed in a metalloproteinase-dependent fashion. The soluble KIM-1 protein that appears in the urine of humans is about 90 KDa. All forms of chronic kidney disease, including diabetes are associated with tubulo-interstitial injury. Aim: The current study was performed try to assess use of urinary KIM-1/Creatinine ratio as a sensitive diagnostic tool for renal injury in the urine of patients with type-2 diabetic Egyptian patients. Methods: Eighty (80) subjects were subjected to clinical examination included and subdivided as 20 apparently healthy control volunteers (group-1) and 60 diabetic patients which were divided into 3 subgroups (Group-2, Group-3 and Group-4) of 20 patients each: According to ACR: (ACR<30 mg/g, 30-299 mg/g and â�?¥300 mg/g respectively). All were subjected to laboratory investigations which included: Morning mid-stream urine sample for: (1) Complete urine analysis, (2) quantitative measurement of urinary albumin, (3) urinary creatinine, (4) calculation of urinary albumin to creatinine ratio, (5) measurement of KIM-1 (ELISA), and (6) calculation of KIM-1 to creatinine ratio. Results: Urinary KIM-1 levels were increased with the progression of nephropathy. Urinary KIM-1 levels were independent risk factor of eGFR and albuminuria in diabetic patients. Urinary KIM-1/Cr ratio was more sensitive than KIM-1. There was no correlation between urinary KIM-1/Cr ratio and GFR in all studied groups. Conclusion: Urinary KIM-1/Cr ratio is a sensitive, noninvasive diagnostic tool for kidney affection in type-2 diabetic Egyptian patients that seem to predict renal injury in early period independent of albuminuria. Due to lack of correlation, both KIM-1/ Cr and Alb/Cr ratios are required to be calculated for type-2 diabetic patients. Recommendations: The use of KIM-1/Cr ratio as a diagnostic tool for kidney affection by measuring it in urine of type-2 diabetic patients at risk of chronic kidney disease.
Biography
Top